Michael J. Fox Foundation Helps Fund TBI Drug Company
Allon Therapeutics Inc. is a biotechnology company based in Vancouver,Canada. The biotech company specializes in the development of drugs that prevent neurodegenerative conditions such as mild cognitive impairment, Alzheimer's, MS, and traumatic brain injury. Allon's leading drug, AL-108, is a drug that has been proven in animal studies to prevent the degeneration of neurons in the brain. The drug has shown promising results in animals with simulated Alzheimer's and stroke.
Continue reading "Michael J. Fox Foundation Helps Fund TBI Drug Company" »
